Cargando…

Interference of M-protein on prothrombin time test – case report

The aim of this report was to present a case of interference on prothrombin time (PT) test that directed further laboratory diagnostics and resulted with final detection of monoclonal gammopathy in an 88-year old man. Routine coagulation testing during medical examination at Emergency Department rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margetić, Sandra, Ćelap, Ivana, Dukić, Lora, Vukasović, Ines, Virović-Jukić, Lucija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Society of Medical Biochemistry and Laboratory Medicine 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910265/ https://www.ncbi.nlm.nih.gov/pubmed/27346971 http://dx.doi.org/10.11613/BM.2016.028

Ejemplares similares

Corrigendum to: Minimum requirements for the estimation of the measurement uncertainty: Recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMB
por: Ćelap, Ivana, et al.
Publicado: (2017)

Minimum requirements for the estimation of measurement uncertainty: Recommendations of the joint Working group for uncertainty of measurement of the CSMBLM and CCMB
por: Ćelap, Ivana, et al.
Publicado: (2017)

Analytical verification and comparison of chromogenic assays for dabigatran, rivaroxaban and apixaban determination on BCSXP and STA Compact Max analysers
por: Ćelap, Ivana, et al.
Publicado: (2020)

Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020)

Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals
por: Bilic-Curcic, Ines, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease – a procoagulant condition?
por: Virović-Jukić, Lucija, et al.
Publicado: (2021)

Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer
por: Bronić, Ana, et al.
Publicado: (2019)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Risk Factors for Colorectal Adenoma – Acknowledging the Burden of NAFLD
por: Duvnjak, Marko, et al.
Publicado: (2019)

Plexiglas barrier box to improve ERCP safety during the COVID-19 pandemic
por: Ljubicic, Neven, et al.
Publicado: (2020)

Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination
por: Ivanko, I., et al.
Publicado: (2023)

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
por: Ogresta, Doris, et al.
Publicado: (2022)

Liver regeneration as treatment target for severe alcoholic hepatitis
por: Virovic-Jukic, Lucija, et al.
Publicado: (2022)

Obesity Paradox in Chronic Liver Diseases: Product of Bias or a Real Thing?
por: Curcic, Ines Bilic, et al.
Publicado: (2019)

Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations
por: Margetić, Sandra, et al.
Publicado: (2019)

ASSOCIATION BETWEEN PERIODONTITIS AND LIVER DISEASE
por: Rinčić, Goran, et al.
Publicado: (2021)

New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis
por: Stojsavljevic-Shapeski, Sanja, et al.
Publicado: (2021)

Haemolysis and lipemia interfere with resistin and myeloperoxidase BioVendor ELISA assays
por: Saracevic, Andrea, et al.
Publicado: (2019)

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation
por: Margetić, Sandra, et al.
Publicado: (2022)

Should we test the prothrombin time in anticoagulated epistaxis patients?
por: Soyka, Michael B., et al.
Publicado: (2013)

Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
por: Balendran, Clare A., et al.
Publicado: (2017)

The progress of prothrombin time measurement
por: Horsti, Juha
Publicado: (2009)

Prothrombin Time in Normal Indians
por: Braganca, Beatriz M., et al.
Publicado: (1946)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
por: Mikolasevic, Ivana, et al.
Publicado: (2022)

Blood gas testing and related measurements: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine
por: Dukić, Lora, et al.
Publicado: (2016)

Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents
por: Budak, Yasemin U., et al.
Publicado: (2012)

Verification policies in Croatian medical biochemistry laboratories: a survey of the practice
por: Milevoj Kopčinović, Lara, et al.
Publicado: (2022)

Institutional practices and policies in acid-base testing: a self reported Croatian survey study on behalf of the Croatian society of medical biochemistry and laboratory medicine Working Group for acid-base balance
por: Dukić, Lora, et al.
Publicado: (2014)

A New Generation Prothrombin Time Method for INR
por: Horsti, Juha, et al.
Publicado: (2008)

Prothrombin Time in Health and Disease. (According to Quick's Method)
por: Reddy, D. V. S., et al.
Publicado: (1941)

Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries
por: Wang, Hui-shan, et al.
Publicado: (2019)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

Wilson's Disease
por: Vukasovic, Ines
Publicado: (2004)

Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
por: Onundarson, Pall T., et al.
Publicado: (2021)

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
por: Bian, Zichen, et al.
Publicado: (2020)

The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
por: Hernaningsih, Yetti, et al.
Publicado: (2017)

Evaluation of Prothrombin Response to Vitamin K as Liver Function Test
por: Wahi, P. N.
Publicado: (1947)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
por: Mansory, Eman M., et al.
Publicado: (2021)

Expression of adipokine ghrelin and ghrelin receptor in human colorectal adenoma and correlation with the grade of dysplasia
por: Stojsavljevic-Shapeski, Sanja, et al.
Publicado: (2021)

Plasma Prothrombin Time and Esophageal Varices in Patients with Cirrhosis of Liver
por: Islam, Md Nasirul, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jvcpkqtdo0l858dj7vmrs5cg28